Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 819246, 6 pages
http://dx.doi.org/10.1155/2013/819246
Research Article

Association of Serum Myeloid Cells of Soluble Triggering Receptor-1 Level with Myocardial Dysfunction in Patients with Severe Sepsis

Department of Critical Care Medicine, Affiliated Hospital of Guangdong Medical College, No. 57 Southern Renmin Avenue, Zhanjiang, Guangdong 524023, China

Received 27 March 2013; Revised 2 June 2013; Accepted 2 June 2013

Academic Editor: Giamila Fantuzzi

Copyright © 2013 Fei Tao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Paoli, S. Valente, D. Ardissino, and G. F. Gensini, “Myocardial dysfunction during sepsis: epidemiology, prognostic significance and treatment,” Giornale Italiano di Cardiologia, vol. 12, no. 12, pp. 804–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Muller-Werdan, M. Buerke, H. Ebelt et al., “Septic cardiomyopathy—a not yet discovered cardiomyopathy?” Experimental and Clinical Cardiology, vol. 1, no. 3, pp. 226–236, 2006. View at Google Scholar · View at Scopus
  3. M. Colonna and F. Facchetti, “TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses,” Journal of Infectious Diseases, vol. 187, supplement 2, pp. S397–S401, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Bouchon, J. Dietrich, and M. Colonna, “Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes,” The Journal of Immunology, vol. 164, no. 10, pp. 4991–4995, 2000. View at Google Scholar · View at Scopus
  5. J. Klesney-Tait, I. R. Turnbull, and M. Colonna, “The TREM receptor family and signal integration,” Nature Immunology, vol. 7, no. 12, pp. 1266–1273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Bleharski, V. Kiessler, C. Buonsanti et al., “A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response,” The Journal of Immunology, vol. 170, no. 7, pp. 3812–3818, 2003. View at Google Scholar · View at Scopus
  7. A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz, and J. E. Parrillo, “Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum,” The Journal of Experimental Medicine, vol. 183, no. 3, pp. 949–958, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Bhalla, S. Willis, and A. S. Maisel, “B-type natriuretic peptide: the level and the drug—partners in the diagnosis of congestive heart failure,” Congestive Heart Failure, vol. 10, no. 1, pp. 3–27, 2004. View at Google Scholar · View at Scopus
  9. D. Atisha, M. A. Bhalla, L. K. Morrison et al., “A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction,” American Heart Journal, vol. 148, no. 3, pp. 518–523, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Nakamura, K. Sakamoto, T. Yamano et al., “Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 39, no. 10, pp. 1657–1663, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Ruwald, J. P. Goetze, J. Bech et al., “NT-ProBNP independently predicts long-term mortality in patients admitted for coronary,” Angiology. In press.
  12. E. Rivers, B. Nguyen, S. Havstad et al., “Early goal-directed therapy in the treatment of severe sepsis and septic shock,” The New England Journal of Medicine, vol. 345, no. 19, pp. 1368–1377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Parrillo, “The cardiovascular pathophysiology of sepsis,” Annual Review of Medicine, vol. 40, pp. 469–485, 1989. View at Google Scholar · View at Scopus
  14. S. Gibot, M. N. Kolopp-Sarda, M. C. Bene, A. Cravoisy, B. Levy, and G. C. Faure, “Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis,” Annals of Internal Medicine, vol. 141, no. 1, pp. 9–15, 2004. View at Google Scholar · View at Scopus
  15. A. Bouchon, F. Facchetti, M. A. Weigand, and M. Colonna, “TREM-1 amplifies inflammation and is a crucial mediator of septic shock,” Nature, vol. 410, no. 6832, pp. 1103–1107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. B. S. Cain, D. R. Meldrum, C. A. Dinarello et al., “Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function,” Critical Care Medicine, vol. 27, no. 7, pp. 1309–1318, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. MacGowan, D. L. Mann, R. L. Kormos, A. M. Feldman, and S. Murali, “Circulating interleukin-6 in severe heart failure,” The American Journal of Cardiology, vol. 79, no. 8, pp. 1128–1131, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Zhou, P. Wang, and I. H. Chaudry, “Cardiac contractility and structure are not significantly compromised even during the late, hypodynamic stage of sepsis,” Shock, vol. 9, no. 5, Article ID 992172, pp. 352–358, 1998. View at Publisher · View at Google Scholar
  19. E. J. Winslow, H. S. Loeb, S. H. Rahimtoola, S. Kamath, and R. M. Gunnar, “Hemodynamic studies and results of therapy in 50 patients with bacteremic shock,” The American Journal of Medicine, vol. 54, no. 4, pp. 421–432, 1973. View at Google Scholar · View at Scopus
  20. M. M. Parker, J. H. Shelhamer, C. Natanson, D. W. Alling, and J. E. Parrillo, “Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis,” Critical Care Medicine, vol. 15, no. 10, pp. 923–929, 1987. View at Google Scholar · View at Scopus
  21. R. F. Wilson, A. P. Thal, P. H. Kindling, T. Grifica, and E. Ackerman, “Hemodynamic measurements in septic shock,” Archives of Surgery, vol. 91, no. 1, pp. 121–129, 1965. View at Publisher · View at Google Scholar
  22. I. Dimopoulou, A. Pelekanou, I. Mavrou et al., “Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression,” Journal of Critical Care, vol. 27, no. 3, pp. 294–300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Gómez-Piña, A. Soares-Schanoski, A. Rodríguez-Rojas et al., “Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes,” The Journal of Immunology, vol. 179, no. 6, pp. 4065–4073, 2007. View at Google Scholar · View at Scopus